🥳Excited to open #TMS2025 conference in beautiful #Pisa 🇮🇹 with my oral presentation:
“New insights from an unstudied collection of Pridoli (Late Silurian) acanthodians in Lithuania 🇱🇹”.

#conference #paleontology #research

Regina Castaneda, MD, on how hormone therapy may influence weight loss outcomes with tirzepatide | Contemporary OB/GYN Study finds women on hormone therapy lost more weight with tirzepatide, though researchers stress association—not causation—needs confirmation.

At #TMS2025, researchers reported menopausal status and hormone therapy use may affect #WeightLoss outcomes with tirzepatide. Women on hormone therapy or pre/perimenopausal lost nearly 20% body weight vs. 15% in untreated postmenopausal peers.

Read more: www.contemporaryobgyn.net/view/regina-...

New insights on hormone therapy and autoimmune disease risk, with Xuezhi Daniel Jiang, MD, PhD | Contemporary OB/GYN New data suggest hormone therapy may increase autoimmune disease risk in postmenopausal women, highlighting need for clinical vigilance.

At #TMS2025, Dr. Xuezhi Daniel Jiang presented data suggesting menopausal #HormoneTherapy may increase the risk of autoimmune disease in postmenopausal women—contrary to expectations. He emphasized the need for more research.

Full video: www.contemporaryobgyn.net/view/new-ins...

Danette Conklin, PhD, discusses cognitive behavioral therapy for menopausal symptom relief | Contemporary OB/GYN CBT adapted for menopause shows benefits for vasomotor symptoms, mood, and sleep, according to Danette Conklin, PhD, at The Menopause Society.

Cognitive behavioral therapy is being adapted to address menopause-related symptoms—including hot flashes, sleep disturbances, and mood changes—according to research presented by Danette Conklin, PhD, at #TMS2025. #CBT

Read more: www.contemporaryobgyn.net/view/danette...

Elinzanetant demonstrates favorable safety profile in menopausal women, with James A. Simon, MD | Contemporary OB/GYN Elinzanetant shows a strong safety profile with no liver toxicity and minimal side effects in menopausal women with vasomotor symptoms.

At #TMS2025, Dr. James A. Simon shared pooled safety data showing that elinzanetant was well tolerated over one year of use for vasomotor symptoms, with no serious or unexplained adverse events reported. #HotFlashes

Read more: www.contemporaryobgyn.net/view/elinzan...

A new study presented at #TMS2025 found that women who experience early natural #menopause face a 27% higher risk of metabolic syndrome compared with those whose menopause occurs later. #HeartHealth

Read more: www.contemporaryobgyn.net/view/early-n...

New research presented at #TMS2025 links menopause to a higher prevalence of dry eye disease, suggesting hormonal changes may contribute to ocular discomfort in midlife women. #Menopause #EyeHealth

Read more: www.contemporaryobgyn.net/view/postmen...

Michelle Wise, MD, discusses levonorgestrel IUD offering effective endometrial protection during hormone therapy | Contemporary OB/GYN Levonorgestrel IUD offers localized progesterone delivery for endometrial protection during hormone therapy, with minimal systemic effects.

At #TMS2025, Michelle Wise, MD, discussed the levonorgestrel IUD as a potential option for endometrial protection during #EstrogenTherapy. While commonly used in some regions, more comparative studies are needed.

Full video: www.contemporaryobgyn.net/view/michell...

Clinical insights into vulvar health in menopause, with Melissa Mauskar, MD | Contemporary OB/GYN Melissa Mauskar, MD, discusses overlapping vulvar conditions, patient counseling, and the importance of multidisciplinary care

At #TMS2025, Dr. Melissa Mauskar emphasized that vulvar conditions in postmenopausal women are often complex and overlapping, highlighting the importance of thorough exams, accurate diagnosis, and patient education. #VulvarHealth

Full video: www.contemporaryobgyn.net/view/clinica...

Preliminary real-world data from the phase 4 OPTION-VMS study show fezolinetant improves #HotFlashes, sleep quality, and daily functioning in postmenopausal women, reinforcing its efficacy as a nonhormonal option. #TMS2025

Read more: www.contemporaryobgyn.net/view/fezolin...

Caroline Mitchell, MD, highlights safety and flexibility in treating GSM | Contemporary OB/GYN At The Menopause Society Annual Meeting, Caroline Mitchell, MD, MPH, emphasized individualized, evidence-based care and the safety of topical hormones for GSM.

Many women believe genitourinary symptoms of #menopause are inevitable and untreatable, but effective therapies exist. Dr. Caroline Mitchell highlights the need for open discussion between patients and clinicians at #TMS2025.

Full video: www.contemporaryobgyn.net/view/carolin...

Experts at #TMS2025 emphasize individualized care in #MenopauseCare. While transdermal hormone therapy may offer mental health advantages, treatment choice should consider each woman’s symptoms and health profile. #PersonalizedMedicine

Read more: www.contemporaryobgyn.net/view/transde...

A study presented at #TMS2025 found that provider specialty and training influence whether women receive #HormoneTherapy or other medications for menopause symptoms. Only 17% of women in the study received pharmacologic treatment.

Read more: www.contemporaryobgyn.net/view/provide...

Helping perimenopausal women make informed contraceptive choices, with Andrew Kaunitz, MD | Contemporary OB/GYN Andrew Kaunitz, MD, shares how older women can explore safe contraceptive options while understanding fertility risks.

Fertility declines with age but doesn’t disappear—about 10% of women remain fertile at 50, said Andrew Kaunitz, MD, at #TMS2025. Continued contraceptive counseling key to preventing #UnintendedPregnancy in perimenopausal women.

Full video: www.contemporaryobgyn.net/view/helping...

Evidence presented at #TMS2025 suggests menopause impacts brain structure and function, with potential links to cognitive decline and mood shifts. Experts call for research to better understand these effects. #BrainHealth

Read more: www.contemporaryobgyn.net/view/menopau...

A study presented at #TMS2025 found postmenopausal women using hormone therapy had a higher incidence of autoimmune diseases compared with non-users. Researchers emphasize individualized care remains key in #MenopauseCare.

Read more: www.contemporaryobgyn.net/view/hormone...

Last day at #TMS2025! If you’re still around, don’t miss the opportunity to learn about the work of our team ⚡️

If you are at #TMS2025 my group is going to give two presentations on the fabrication of coated particle fuel and the use of machine learning for nuclear fuel performance. See information below.

Zijun Wang is presenting a poster at TMS 2025, held March 23–27 in Las Vegas, Nevada. His work will be available at poster SPG-8 during the annual meeting organized by The Minerals, Metals & Materials Society. A great chance to catch up on current research!

#TMSAnnualMeeting #TMS2025

At 5:30 PM (Marquee Ballroom, D-58), Nensi Toncich will be presenting her poster on Reactive Multilayer Induced Self-Healing in Thin Films – The Importance of Diffusion Barriers. Swing by and check it out!

#TMS2025 #TMSAnnualMeeting
@ethzurich.bsky.social

Early birds at #TMS2025! Join us to kickstart LNM's talks tomorrow at 8:30 AM (Room 315) with Nerea Abando's presentation on Multi-Material AM of Shape Memory Alloys for Tunable Mechanical Responses. Don't miss it! 🦾🚀

#TMSAnnualMeeting @ethzurich.bsky.social

Greetings from Las Vegas! 🌴

LNM is attending #TMS2025 next week!
Stay tuned for updates on our talks.

On the meantime, you may spot some LNM members exploring the city 😎

#TMSAnnualMeeting #LNMonTour @TMSSociety
@ethzurich.bsky.social

Coming to #TMS2025 ! If you are coming too, please check out the talks/poster from my group, see image :). See you there!

🚀 #TMS2025 is just around the corner! If you're attending, don’t miss Dr. Rika Kobayashi’s talk on computational modeling in materials science and how high-performance computing (HPC) is driving innovation in energy materials.
📅 Date: March 24, 2025
⏰ Time: 9:40–10:05 AM

Thrilled to share our latest tools for self-driving labs & autonomous experiments at #TMS2025 with Sparks Group! We'll cover many topics from hardware to software, and more. Join us in Vegas, Mar 24–27! #AI #MaterialsScience #Research #SDL